Papers/PMID:19584739
The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia.
International clinical psychopharmacology2009The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
melatonin — decreases sleep onset latency
PreliminaryGrade D, Preliminary. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×8“By the end of the double-blind treatment, the PRM group had significantly shorter sleep onset latency (9 min; P = 0.02) compared with the placebo group and scored significantly better in the Critical Flicker Fusion Test (P = 0.008) without negatively affecting sleep structure and architecture.”
Quoted verbatim from The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia.. - Study
- RCT
- Duration
- 3 weeks
- Dose
- prolonged-release melatonin 2 mg nightly
- Population
- Adults aged 55 years and older with primary insomnia (DSM-IV)
The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia.2009PMID:19584739Permalink